{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Reactive oxygen species", "alcoholic liver disease", "herbal medicine", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38074830", "DateRevised": {"Year": "2023", "Month": "12", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "15"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1943-8141", "JournalIssue": {"Volume": "15", "Issue": "11", "PubDate": {"Year": "2023"}}, "Title": "American journal of translational research", "ISOAbbreviation": "Am J Transl Res"}, "ArticleTitle": "Reactive oxygen species (ROS)-mediated oxidative stress in chronic liver diseases and its mitigation by medicinal plants.", "Pagination": {"StartPage": "6321", "EndPage": "6341", "MedlinePgn": "6321-6341"}, "Abstract": {"AbstractText": ["Reactive oxygen species (ROS) play a crucial role in cell survival regulation, and its low levels may act as indicators to encourage cellular proliferation. In contrast, elevated levels of ROS may lead to apoptosis. Stability between generating and eliminating ROS allows the retention of effective functioning of redox-sensitive signaling proteins under physiologic conditions. Cells typically maintain redox homeostasis to guarantee appropriate responses to internal and external stimuli. However, oxidative stress occurs when the oxidation product level exceeds the number of standard antioxidant systems. ROS can cause harm to all types of hepatic cells, including endothelial cells, hepatocytes, Kupffer cells, and stellate cells. High levels of ROS may lead to tissue edema, ischemia, fibrosis, cell death, or malignant transformation and may eventually lead to complete tissue damage. Antioxidants in our body exist in a homeostatic balance with other enzymes involved in the repair of cellular functions in addition to the non-enzymatic molecules such as urate, bilirubin, several vitamins, and reduced glutathione to maintain the levels of ROS in the interest of cellular homeostasis. This balance may, however, get disturbed in case of acute or chronic liver injury due to the accumulation of ROS. In the current manuscript, we aim to review the relevance of oxidative stress and its indicator of liver injury in chronic liver diseases such as alcoholic and non-alcoholic fatty liver diseases and hepatitis. Since reactive oxidation species may also lead to lipid peroxidation and promote ferroptosis, we have also evaluated their impact on epigenetic modifications, such as oxidative damage to histone proteins and DNA methylation, and the differential expression of genes related to cellular injury. We also want to highlight the potential of traditional herbal medicines as redox regulators for managing chronic liver diseases."], "CopyrightInformation": "AJTR Copyright \u00a9 2023."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University Pushp Vihar 10017, New Delhi, India."}], "LastName": "Sharma", "ForeName": "Priyanka", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University Pushp Vihar 10017, New Delhi, India."}], "LastName": "Nandave", "ForeName": "Mukesh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dravyaguna Vigyan, All India Institute of Ayurveda New Delhi, India."}], "LastName": "Nandave", "ForeName": "Dipali", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Chhatrapati Shahu Ji Maharaj University Kanpur 208024, Uttar Pradesh, India."}], "LastName": "Yadav", "ForeName": "Shivam", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Bromatology and Toxicology, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos Lima 15081, Peru."}, {"Identifier": [], "Affiliation": "E-Health Research Center, Universidad de Ciencias y Humanidades Lima 15314, Peru."}], "LastName": "Vargas-De-La-Cruz", "ForeName": "Celia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University) Mullana-Ambala 133207, Haryana, India."}], "LastName": "Singh", "ForeName": "Sukhbir", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Health Science and Technology Institute, NCR Biotech Science Cluster 3rd Milestone, Faridabad-Gurugram Expressway, PO Box #04, Faridabad 121001, Haryana, India."}], "LastName": "Tandon", "ForeName": "Ruchi", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University Centre for Research and Development, University of Biotechnology, Chandigarh University Gharuan, Mohali 140413, Punjab, India."}], "LastName": "Ramniwas", "ForeName": "Seema", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity School of Pharmaceutical Sciences, Amity University Mohali 140306, Punjab, India."}], "LastName": "Behl", "ForeName": "Tapan", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Transl Res", "NlmUniqueID": "101493030", "ISSNLinking": "1943-8141"}, "CoiStatement": "None."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12:231\u201342.", "ArticleIdList": ["25782093"]}, {"Citation": "Bose Mazumdar Ghosh A, Banerjee A, Chattopadhyay S. An insight into the potent medicinal plant Phyllanthus amarus Schum. and Thonn. Nucleus (Calcutta) 2022;65:437\u2013472.", "ArticleIdList": ["PMC9660160", "36407559"]}, {"Citation": "Chhikara N, Kaur A, Mann S, Garg MK, Sofi SA, Panghal A. Bioactive compounds, associated health benefits and safety considerations of Moringa oleifera L.: an updated review. Nutrition & Food Science. 2021;51:255\u201377."}, {"Citation": "Emanuele NV, Swade TF, Emanuele MA. Consequences of alcohol use in diabetics. Alcohol Health Res World. 1998;22:211\u20139.", "ArticleIdList": ["PMC6761899", "15706798"]}, {"Citation": "Contreras-Zentella ML, Villalobos-Garc\u00eda D, Hern\u00e1ndez-Mu\u00f1oz R. Ethanol metabolism in the liver, the induction of oxidant stress, and the antioxidant defense system. Antioxidants (Basel) 2022;11:1258.", "ArticleIdList": ["PMC9312216", "35883749"]}, {"Citation": "Shao M, Wang Y, Dong H, Wang L, Zhang X, Han X, Sang X, Bao Y, Peng M, Cao G. From liver fibrosis to hepatocarcinogenesis: role of excessive liver H2O2 and targeting nanotherapeutics. Bioact Mater. 2022;23:187\u2013205.", "ArticleIdList": ["PMC9663332", "36406254"]}, {"Citation": "Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56:1384\u201391.", "ArticleIdList": ["22326465"]}, {"Citation": "Rouf R, Ghosh P, Uzzaman MR, Sarker DK, Zahura FT, Uddin SJ, Muhammad I. Hepatoprotective plants from Bangladesh: a biophytochemical review and future prospect. Evid Based Complement Alternat Med. 2021;2021:1633231.", "ArticleIdList": ["PMC8423546", "34504532"]}, {"Citation": "Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. Eur J Sport Sci. 2019;19:994\u20131003.", "ArticleIdList": ["30732555"]}, {"Citation": "Gu X, Manautou JE. Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med. 2012;14:e4.", "ArticleIdList": ["PMC3704158", "22306029"]}, {"Citation": "Diesen DL, Kuo PC. Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention. J Surg Res. 2011;167:96\u2013112.", "ArticleIdList": ["PMC2907433", "20400112"]}, {"Citation": "Zafrani ES. Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch. 2004;444:3\u201312.", "ArticleIdList": ["14685853"]}, {"Citation": "Mueller S, Seitz HK, Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol. 2014;20:14626\u201341.", "ArticleIdList": ["PMC4209529", "25356026"]}, {"Citation": "Radi R. Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine. Proc Natl Acad Sci U S A. 2018;115:5839\u20135848.", "ArticleIdList": ["PMC6003358", "29802228"]}, {"Citation": "Sugimoto K, Takei Y. Pathogenesis of alcoholic liver disease. Hepatol Res. 2017;47:70\u201379.", "ArticleIdList": ["27138729"]}, {"Citation": "Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol. 2014;20:17756\u201372.", "ArticleIdList": ["PMC4273126", "25548474"]}, {"Citation": "Chhimwal J, Goel A, Sukapaka M, Patial V, Padwad Y. Phloretin mitigates oxidative injury, inflammation, and fibrogenic responses via restoration of autophagic flux in in vitro and preclinical models of NAFLD. J Nutr Biochem. 2022;107:109062.", "ArticleIdList": ["35609858"]}, {"Citation": "Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol. 2009;83:519\u201348.", "ArticleIdList": ["19448996"]}, {"Citation": "Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, Federico A, Persico M. Role of oxidative stress in pathophysiology of non-alcoholic fatty liver disease. Oxid Med Cell Longev. 2018:2018.", "ArticleIdList": ["PMC6016172", "29991976"]}, {"Citation": "Di Meo S, Reed TT, Venditti P, Victor VM. Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longev. 2016;2016:1245049.", "ArticleIdList": ["PMC4960346", "27478531"]}, {"Citation": "Norberg A, Jones AW, Hahn RG, Gabrielsson JL. Role of variability in explaining ethanol pharmacokinetics: research and forensic applications. Clin Pharmacokinet. 2003;42:1\u201331.", "ArticleIdList": ["12489977"]}, {"Citation": "Alfadda AA, Sallam RM. Reactive oxygen species in health and disease. J Biomed Biotechnol. 2012;2012:936486.", "ArticleIdList": ["PMC3424049", "22927725"]}, {"Citation": "Pisoschi AM, Pop A, Iordache F, Stanca L, Predoi G, Serban AI. Oxidative stress mitigation by antioxidants - an overview on their chemistry and influences on health status. Eur J Med Chem. 2021;209:112891.", "ArticleIdList": ["33032084"]}, {"Citation": "Semwal DK, Chauhan A, Kumar A, Aswal S, Semwal RB, Kumar A. Status of Indian medicinal plants in the International Union for Conservation of Nature and the future of Ayurvedic drugs: shouldn\u2019t think about Ayurvedic fundamentals? J Integr Med. 2019;17:238\u2013243.", "ArticleIdList": ["31076374"]}, {"Citation": "Costa VM, Carvalho F, Duarte JA, Bastos Mde L, Remi\u00e3o F. The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress. Chem Res Toxicol. 2013;26:1285\u2013311.", "ArticleIdList": ["23902227"]}, {"Citation": "Wu A, Feng B, Yu J, Yan L, Che L, Zhuo Y, Luo Y, Yu B, Wu D, Chen D. Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biology. 2021;46:102131.", "ArticleIdList": ["PMC8445902", "34530349"]}, {"Citation": "Melhem A, Stern M, Shibolet O, Israeli E, Ackerman Z, Pappo O, Hemed N, Rowe M, Ohana H, Zabrecky G, Cohen R, Ilan Y. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol. 2005;39:737\u201342.", "ArticleIdList": ["16082287"]}, {"Citation": "Tretter V, Hochreiter B, Zach ML, Krenn K, Klein KU. Understanding cellular redox homeostasis: a challenge for precision medicine. Int J Mol Sci. 2021;23:106.", "ArticleIdList": ["PMC8745322", "35008532"]}, {"Citation": "Lakshman R, Cederbaum AI, Hoek JB, Konishi M, Koop D, Donohu TM. Use of CYP2E1-transfected human liver cell lines in elucidating the actions of ethanol. Alcohol Clin Exp Res. 2005;29:1726\u201334.", "ArticleIdList": ["16205373"]}, {"Citation": "Qadan M, Garden OJ, Corvera CU, Visser BC. Management of postoperative hepatic failure. J Am Coll Surg. 2016;222:195\u2013208.", "ArticleIdList": ["26705902"]}, {"Citation": "Pocard M, Vincent-Salomon A, Girodet J, Salmon RJ. Effects of preoperative chemotherapy on liver function tests after hepatectomy. Hepatogastroenterology. 2001;48:1406\u20138.", "ArticleIdList": ["11677975"]}, {"Citation": "Nagakannan P, Tabeshmehr P, Eftekharpour E. Oxidative damage of lysosomes in regulated cell death systems: pathophysiology and pharmacologic interventions. Free Radic Biol Med. 2020;157:94\u2013127.", "ArticleIdList": ["32259579"]}, {"Citation": "Miller MA, Zachary JF. Mechanisms and morphology of cellular injury, adaptation, and death. Pathologic Basis of Veterinary Disease. 2017:2."}, {"Citation": "Mooli RGR, Mukhi D, Ramakrishnan SK. Oxidative stress and redox signaling in the pathophysiology of liver diseases. Compr Physiol. 2022;12:3167\u20133192.", "ArticleIdList": ["PMC10074426", "35578969"]}, {"Citation": "Chen Y, Wang Y, Jiang S, Xu J, Wang B, Sun X, Zhang Y. Red-fleshed apple flavonoid extract alleviates CCl4-induced liver injury in mice. Front Nutr. 2023;9:1098954.", "ArticleIdList": ["PMC9890596", "36742007"]}, {"Citation": "Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Marrogi AJ, Harris CC. Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci U S A. 2000;97:12770\u20135.", "ArticleIdList": ["PMC18839", "11050162"]}, {"Citation": "Wenzel G, Kuklinski B, R\u00fchlmann C, Ehrhardt D. Alcohol-induced toxic hepatitis--a \u201cfree radical\u201d associated disease. Lowering fatality by adjuvant antioxidant therapy. Z Gesamte Inn Med. 1993;48:490\u20136.", "ArticleIdList": ["8256468"]}, {"Citation": "Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O\u2019Grady J. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol. 2006;44:784\u201390.", "ArticleIdList": ["16469404"]}, {"Citation": "Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D, Record C, Day CP. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol. 2007;47:277\u201383.", "ArticleIdList": ["17532088"]}, {"Citation": "Mezey E, Potter JJ, Rennie-Tankersley L, Caballeria J, Pares A. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol. 2004;40:40\u20136.", "ArticleIdList": ["14672612"]}, {"Citation": "Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37\u201346.", "ArticleIdList": ["15537682"]}, {"Citation": "Mato JM, C\u00e1mara J, Fern\u00e1ndez de Paz J, Caballer\u00eda L, Coll S, Caballero A, Garc\u00eda-Buey L, Beltr\u00e1n J, Benita V, Caballer\u00eda J, Sol\u00e0 R, Moreno-Otero R, Barrao F, Mart\u00edn-Duce A, Correa JA, Par\u00e9s A, Barrao E, Garc\u00eda-Magaz I, Puerta JL, Moreno J, Boissard G, Ortiz P, Rod\u00e9s J. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. 1999;30:1081\u20139.", "ArticleIdList": ["10406187"]}, {"Citation": "Casals G, Perram\u00f3n M, Casals E, Portol\u00e9s I, Fern\u00e1ndez-Varo G, Morales-Ruiz M, Puntes V, Jim\u00e9nez W. Cerium oxide nanoparticles: a new therapeutic tool in liver diseases. Antioxidants (Basel) 2021;10:660.", "ArticleIdList": ["PMC8146351", "33923136"]}, {"Citation": "Ramos-Tovar E, Muriel P. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage. J Appl Toxicol. 2020;40:151\u2013168.", "ArticleIdList": ["31389060"]}, {"Citation": "Madkour LH. Reactive oxygen species (ROS), nanoparticles, and endoplasmic reticulum (ER) stress-induced cell death mechanisms. Academic Press; 2020."}, {"Citation": "Von Herbay A, Stahl W, Niederau C, Sies H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free Radic Res. 1997;27:599\u2013605.", "ArticleIdList": ["9455695"]}, {"Citation": "Garbuzenko DV, Arefyev NO. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: an update and review of the literature. J Evid Based Med. 2020;13:313\u201324.", "ArticleIdList": ["33037792"]}, {"Citation": "Gabbay E, Zigmond E, Pappo O, Hemed N, Rowe M, Zabrecky G, Cohen R, Ilan Y. Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol. 2007;13:5317\u201323.", "ArticleIdList": ["PMC4171320", "17879400"]}, {"Citation": "Videla LA, Valenzuela R. Perspectives in liver redox imbalance: toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action. Biofactors. 2022;48:400\u2013415.", "ArticleIdList": ["34687092"]}, {"Citation": "Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116\u2013141.", "ArticleIdList": ["32156524"]}, {"Citation": "Circu ML, Aw TY. Glutathione and modulation of cell apoptosis. Biochim Biophys Acta. 2012;1823:1767\u201377.", "ArticleIdList": ["PMC3437743", "22732297"]}, {"Citation": "Saha S, Sadhukhan P, Sil PC. Mangiferin: a xanthonoid with multipotent anti-inflammatory potential. Biofactors. 2016;42:459\u2013474.", "ArticleIdList": ["27219011"]}, {"Citation": "Li HY, Gan RY, Shang A, Mao QQ, Sun QC, Wu DT, Geng F, He XQ, Li HB. Plant-based foods and their bioactive compounds on fatty liver disease: effects, mechanisms, and clinical application. Oxid Med Cell Longev. 2021;2021:6621644.", "ArticleIdList": ["PMC7939748", "33728021"]}, {"Citation": "Hu S, Li SW, Yan Q, Hu XP, Li LY, Zhou H, Pan LX, Li J, Shen CP, Xu T. Natural products, extracts and formulations comprehensive therapy for the improvement of motor function in alcoholic liver disease. Pharmacol Res. 2019;150:104501.", "ArticleIdList": ["31689520"]}, {"Citation": "Chen J, Hu Y, Chen L, Liu W, Mu Y, Liu P. The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases. Biomed Pharmacother. 2019;114:108846.", "ArticleIdList": ["30965233"]}, {"Citation": "Zobeiri M, Belwal T, Parvizi F, Naseri R, Farzaei MH, Nabavi SF, Sureda A, Nabavi SM. Naringenin and its nano-formulations for fatty liver: cellular modes of action and clinical perspective. Curr Pharm Biotechnol. 2018;19:196\u2013205.", "ArticleIdList": ["29766801"]}, {"Citation": "Woolbright BL, Jaeschke H. Mechanisms of inflammatory liver injury and drug-induced hepatotoxicity. Curr Pharmacol Rep. 2018;4:346\u2013357.", "ArticleIdList": ["PMC6294466", "30560047"]}, {"Citation": "Ali H, Assiri MA, Shearn CT, Fritz KS. Lipid peroxidation derived reactive aldehydes in alcoholic liver disease. Curr Opin Toxicol. 2019;13:110\u2013117.", "ArticleIdList": ["PMC6602539", "31263795"]}, {"Citation": "Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC. Mitochondrial oxidative stress and antioxidants balance in fatty liver disease. Hepatol Commun. 2018;2:1425\u20131439.", "ArticleIdList": ["PMC6287487", "30556032"]}, {"Citation": "Pundir R, Singh G, Pandey AA, Saraf SA. Demand of herbal hepatoprotective formulations in Lucknow-a survey. Pharma Research. 2009;1:23\u201333."}, {"Citation": "Panda AK, Bhuyan GC, Rao MM. Ayurvedic intervention for hepatobiliary disorders: current scenario and future prospect. J Tradit Med Clin Natur. 2017;6:2."}, {"Citation": "Batey RG, Salmond SJ, Bensoussan A. Complementary and alternative medicine in the treatment of chronic liver disease. Curr Gastroenterol Rep. 2005;7:63\u201370.", "ArticleIdList": ["15701301"]}, {"Citation": "Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. Hepatoprotective activity of six polyherbal formulations in paracetamol induced liver toxicity in mice. Indian J Med Res. 2009;129:569\u201378.", "ArticleIdList": ["19675387"]}, {"Citation": "Bendale Y, Bendale V, Bhavar G. Effect of virechana karma with matra basti in the management of jalodara (Ascites) AYU (An International Quarterly Journal of Research in Ayurveda) 2016;37:254\u2013259."}, {"Citation": "Ranasinghe R, Mathai M, Zulli A. Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress. Life Sci. 2023;318:121466.", "ArticleIdList": ["36773693"]}, {"Citation": "Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med. 2008;29:9\u201316.", "ArticleIdList": ["18045675"]}, {"Citation": "Lu ZM, Tao WY, Xu HY, Ao ZH, Zhang XM, Xu ZH. Further studies on the hepatoprotective effect of Antrodia camphorata in submerged culture on ethanol-induced acute liver injury in rats. Nat Prod Res. 2011;25:684\u201395.", "ArticleIdList": ["20623423"]}, {"Citation": "Kumar Rajagopal S, Manickam P, Periyasamy V, Namasivayam N. Activity of cassia auriculata leaf extract in rats with alcoholic liver injury. J Nutr Biochem. 2003;14:452\u20138.", "ArticleIdList": ["12948875"]}, {"Citation": "Zhang J, Xue J, Wang H, Zhang Y, Xie M. Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress. Phytother Res. 2011;25:638\u201343.", "ArticleIdList": ["20981870"]}, {"Citation": "Du J, He D, Sun LN, Han T, Zhang H, Qin LP, Rahman K. Semen Hoveniae extract protects against acute alcohol-induced liver injury in mice. Pharm Biol. 2010;48:953\u20138.", "ArticleIdList": ["20673184"]}, {"Citation": "Lian LH, Wu YL, Song SZ, Wan Y, Xie WX, Li X, Bai T, Ouyang BQ, Nan JX. Gentiana manshurica Kitagawa reverses acute alcohol-induced liver steatosis through blocking sterol regulatory element-binding protein-1 maturation. J Agric Food Chem. 2010;58:13013\u20139.", "ArticleIdList": ["21105651"]}, {"Citation": "Kundu R, Dasgupta S, Biswas A, Bhattacharya A, Pal BC, Bandyopadhyay D, Bhattacharya S, Bhattacharya S. Cajanus cajan Linn. (Leguminosae) prevents alcohol-induced rat liver damage and augments cytoprotective function. J Ethnopharmacol. 2008;118:440\u20137.", "ArticleIdList": ["18584980"]}, {"Citation": "Bapte PS, Pansambal SS, Borgave S. Biosynthesized selenium nanoparticles: an excellent bait for antioxidant therapy. Journal of Nanostructures. 2022;12:178\u201393."}, {"Citation": "Wang H, Mehal W, Nagy LE, Rotman Y. Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell Mol Immunol. 2021;18:73\u201391.", "ArticleIdList": ["PMC7852578", "33268887"]}, {"Citation": "Shi QZ, Wang LW, Zhang W, Gong ZJ. Betaine inhibits toll-like receptor 4 expression in rats with ethanol-induced liver injury. World J Gastroenterol. 2010;16:897\u2013903.", "ArticleIdList": ["PMC2825338", "20143470"]}, {"Citation": "Yoon SJ, Koh EJ, Kim CS, Zee OP, Kwak JH, Jeong WJ, Kim JH, Lee SM. Agrimonia eupatoria protects against chronic ethanol-induced liver injury in rats. Food Chem Toxicol. 2012;50:2335\u201341.", "ArticleIdList": ["22525864"]}, {"Citation": "Samuhasaneeto S, Thong-Ngam D, Kulaputana O, Suyasunanont D, Klaikeaw N. Curcumin decreased oxidative stress, inhibited NF-kappaB activation, and improved liver pathology in ethanol-induced liver injury in rats. J Biomed Biotechnol. 2009;2009:981963.", "ArticleIdList": ["PMC2709731", "19606259"]}, {"Citation": "Khan AQ, Nafees S, Sultana S. Perillyl alcohol protects against ethanol induced acute liver injury in Wistar rats by inhibiting oxidative stress, NF\u03ba-B activation and proinflammatory cytokine production. Toxicology. 2011;279:108\u201314.", "ArticleIdList": ["20923693"]}, {"Citation": "You M, Crabb DW. Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins. Alcohol. 2004;34:39\u201343.", "ArticleIdList": ["15670664"]}, {"Citation": "Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res. 2009;33:191\u2013205.", "ArticleIdList": ["PMC2633431", "19032584"]}, {"Citation": "Yin HQ, Je YT, Kim YC, Shin YK, Sung S, Lee K, Jeong GS, Kim YC, Lee BH. Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c. J Pharmacol Sci. 2009;109:486\u201395.", "ArticleIdList": ["19372631"]}, {"Citation": "Chen KH, Li PC, Lin WH, Chien CT, Low BH. Depression by a green tea extract of alcohol-induced oxidative stress and lipogenesis in rat liver. Biosci Biotechnol Biochem. 2011;75:1668\u201376.", "ArticleIdList": ["21897050"]}, {"Citation": "Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol. 2008;295:G833\u201342.", "ArticleIdList": ["PMC2575919", "18755807"]}, {"Citation": "Yin HQ, Kim YC, Chung YS, Kim YC, Shin YK, Lee BH. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes. Toxicol Appl Pharmacol. 2009;236:124\u201330.", "ArticleIdList": ["19371623"]}, {"Citation": "Lv X, Chen Z, Li J, Zhang L, Liu H, Huang C, Zhu P. Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress. Inflamm Res. 2010;59:635\u201345.", "ArticleIdList": ["20221667"]}, {"Citation": "Yun JW, Kim YK, Lee BS, Kim CW, Hyun JS, Baik JH, Kim JJ, Kim BH. Effect of dietary epigallocatechin-3-gallate on cytochrome P450 2E1-dependent alcoholic liver damage: enhancement of fatty acid oxidation. Biosci Biotechnol Biochem. 2007;71:2999\u20133006.", "ArticleIdList": ["18071271"]}, {"Citation": "Wasmuth HE, Kunz D, Yagmur E, Timmer-Strangh\u00f6ner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM, Matern S, Lammert F. Patients with acute on chronic liver failure display \u201csepsis-like\u201d immune paralysis. J Hepatol. 2005;42:195\u2013201.", "ArticleIdList": ["15664244"]}, {"Citation": "Leon CG, Tory R, Jia J, Sivak O, Wasan KM. Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm Res. 2008;25:1751\u201361.", "ArticleIdList": ["PMC2469272", "18493843"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "13"}, {"Year": "2023", "Month": "10", "Day": "11"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "6", "Minute": "46"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "6", "Minute": "45"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "5", "Minute": "48"}, {"Year": "2023", "Month": "11", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["38074830", "PMC10703659"]}}], "PubmedBookArticle": []}